PreMarket Price
PreMarket Price
Solstice Advanced Materials Inc. Common Stock (SOLS) logo

Stock Analysis

Solstice Advanced Materials Inc. Common StockSOLS

Price:$59.25Market Closed-1.12%at last close

P/E 44.82×· 5Y range 32.57–74.05×· 28th percentile of history

Sector: Basic Materials · Industry: Chemicals & Allied Products

AnalystsStrong Buy13 analysts
Mkt Cap 9.34BP/E 44.5ROE 14.9%
Low 32.6×44.8×High 74.0×

P/E 44.8× sits at the 28th percentile of its 4.791124800365047-year history.

Cash $0.53BNet debt $1.43BDebt $1.97B

Cash covers 27% of debt · FY 2025.

Profilev57g50p57h42q52m58

PMP Verdict

Mixed fundamentals, fairly valued

Risks

  • Financial Health42
  • Growth50
Revenue +1108.3% CAGRP/E 44× · 28th pctl

Mixed picture — no clear quality or value edge.

Bull Case

  • ✓Revenue CAGR 1108.3% — durable top-line growth

What's happening with SOLS

Last big move: +5.1% on 2026-10-06

Profile

Valuation — 57/100 (Moderate) P/E vs own history: 28th pct → 20/25 FCF yield: 2.1% → 5/25 P/S: 2.3x → 20/25 EV/EBIT: 17.6x → 12/25Valuation57Growth — 50/100 (Moderate) Revenue CAGR: 1108.3% → 25/25 Net income CAGR: n/a → 0/25 EPS CAGR 5Y: n/a → 0/25 Fwd implied growth: 117.9% → 25/25Growth50Profitability — 57/100 (Moderate) ROIC: 17.0% → 20/25 ROE: 14.9% → 12/25 Net margin: 5.1% → 13/25 Operating margin: 14.9% → 12/25Profitability57Financial Health — 42/100 (Weak) Altman Z: 2.52 → 18/25 Current ratio: 1.39 → 12/25 Interest coverage: -28.5x → 0/25 Net cash / debt: D/A 25% → 12/25Health42Quality — 52/100 (Moderate) Piotroski F: 3/9 → 5/25 Beneish M: -3.46 → 25/25 FCF conversion: 93% → 22/25 Margin stability: σ 748.2% → 0/25Quality52Moat — 58/100 (Moderate) ROIC >12% years: 3/4 yrs → 20/25 Median gross margin: 34.6% → 13/25 FCF-positive years: 4/4 yrs → 25/25 Worst-year net margin: worst -2482.2% → 0/25Moat58

financial health lags behind.

How is each axis scored?
  • Valuation57/100 · Moderate
    • P/E vs own history (28th pct)20/25
    • FCF yield (2.1%)5/25
    • P/S (2.3x)20/25
    • EV/EBIT (17.6x)12/25
  • Growth50/100 · Moderate
    • Revenue CAGR (1108.3%)25/25
    • Net income CAGR (n/a)0/25
    • EPS CAGR 5Y (n/a)0/25
    • Fwd implied growth (117.9%)25/25
  • Profitability57/100 · Moderate
    • ROIC (17.0%)20/25
    • ROE (14.9%)12/25
    • Net margin (5.1%)13/25
    • Operating margin (14.9%)12/25
  • Financial Health42/100 · Weak
    • Altman Z (2.52)18/25
    • Current ratio (1.39)12/25
    • Interest coverage (-28.5x)0/25
    • Net cash / debt (D/A 25%)12/25
  • Quality52/100 · Moderate
    • Piotroski F (3/9)5/25
    • Beneish M (-3.46)25/25
    • FCF conversion (93%)22/25
    • Margin stability (σ 748.2%)0/25
  • Moat58/100 · Moderate
    • ROIC >12% years (3/4 yrs)20/25
    • Median gross margin (34.6%)13/25
    • FCF-positive years (4/4 yrs)25/25
    • Worst-year net margin (worst -2482.2%)0/25

Risk Flags

  • ⚠2 loss-making years in recent history
  • ⚠Interest coverage -28.5× — thin debt cushion

About Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. Show more

It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

Headquarters: MORRIS PLAINS, NJ · Employees: 4,400 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
4.1B+11%
Op. Income
611M-26%
Net Income
210M-63%
EPS
1.32-63%
Operating CF
606M-26%
Free CF
195M-63%

Valuation

57C
P/E (TTM)44.5xD

Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 32.6x–74.0x · 28th pct

P/FCF31.0xC

Grade C: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative · Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

FCF Yield2.1%C

Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 0.8%–2.2% · 85th pct · Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

P/S (TTM)2.28xB

Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 2.0x–3.6x · 19th pct

EV/EBIT17.6xB

Grade B: FairEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 14.1x–26.4x · 20th pct

EV/Sales2.7xB

Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E20.4xB

Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio6.62xC

Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio—

Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield—

TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio632.9%D

Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 5Y historyBelow average · 28th pct

Elevated investment: Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

Profitability

57C
ROIC17.0%A

Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE14.9%C

Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks

ROA3.7%D

Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin5.1%C

Grade C: AverageNet Income / Revenue

Operating Margin14.9%C

Grade C: AverageTTM EBIT / TTM Revenue

Gross Margin30.6%C

Grade C: AverageGross Profit / Revenue

FCF Margin4.8%D

Grade D: LowFCF / Revenue · Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

True FCF Margin4.1%D

Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost · Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

Growth

50C
Revenue CAGR1108.3%A

Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR—

Compound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)—

Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth117.9%A

Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)—

Share count change over 5Y

SBC / Net Income12.4%C

Grade C: MedStock-based comp/Net income. >30% = dilution risk

SBC / Revenue0.6%A

Grade A: LowTTM stock-based comp / TTM Revenue

Financial Health

42D+
Altman Z-Score2.52C

Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio1.39xC

Grade C: OkCurrent Assets/Liabilities

Quick Ratio1.08xA

Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage-28.5xD

Grade D: RiskyEBIT/Interest. >10 Strong

Debt Repayment7.4yC

Grade C: AverageYears to repay net debt via FCF · Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

Net Debt/EBIT2.3xC

Grade C: MedLeverage. <2x Low, >4x High

Debt/Equity1.39xC

Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt0.27xD

Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash

Quality

52C
Piotroski F-Score3/9D

Grade D: WeakFinancial strength 0–9. >7 Strong

Beneish M-Score-3.46A

Grade A: SafeEarnings manipulation risk. < -2.22 Safe

FCF Conversion92.9%A

Grade A: StrongFCF / Net Income · Elevated investment — CapEx = 68% of operating cash flow, weighing on reported FCF

Margin Stability748.2%D

Grade D: VolatileEBIT margin std deviation. Lower = stable

Capex / Revenue10.0%C

Grade C: AverageTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover0.73xC

Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

2/6 Loss Years

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell —Other filings 15No open-market trades

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Dormo Jeffrey Harrison
Filed
Grant / award
+9
Dormo Jeffrey Harrison
Filed
Grant / award
+12
Dormo Jeffrey Harrison
Filed
Grant / award
+4
Dormo Jeffrey Harrison
Filed
Grant / award
+7
Dormo Jeffrey Harrison
Filed
Grant / award
+2
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
Dormo Jeffrey Harrison
Filed
Grant / award
+24
Mawson Simon
Filed
Grant / award
+7
Mawson Simon
Filed
Grant / award
+8
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

58C
ROIC >12% Years3/4 yrsA

Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)34.6%C

Grade C: ModerateMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years4/4 yrsA

Grade A: DurableShare of completed fiscal years with positive free cash flow

Net Margin Floor-2482.2%D

Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)$1.32

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$4.72

Cash & short-term investments per share (Finnhub)

Book Value / Share$9.98

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$1.97B

Total debt obligations (short + long term)

Cash & Equiv.$534.00M

Cash and short-term investments

Net Debt$1.43B

Total Debt minus Cash. Negative = Net Cash position

Total Equity$1.41B

Shareholders' equity (book value)

Asset / Liability1.32xC

Grade C: AdequateTotal Assets / Total Liabilities

Market

Market Cap$9.34B

Current Market Capitalization

Beta0.21B

Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Solstice Advanced Materials Inc. Common Stock (SOLS)

SOLS is down 1.12% at the last close. Solstice Advanced Materials Inc. Common Stock meets only 3 of 9 Piotroski F-Score criteria — a sign of weak underlying fundamentals. Altman Z-Score of 2.52 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -3.46 suggests a low likelihood of earnings manipulation.

  • Revenue has compounded at roughly 1108% annually — a strong growth profile.
  • Takes ~7.4 years to repay net debt from free cash flow.
  • Interest coverage of -28.5× leaves little room for earnings shocks.
  • Solstice Advanced Materials Inc. Common Stock posted a net loss in 2 of 6 available completed fiscal years (2020–2025).

See how SOLS ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all SOLS moves →
DateSessionPriceMoveZ-Score
Oct 6Regular61.02+5.10%2.64
Oct 6After-hours61.60+6.10%3.09
Sep 30Pre-market58.39+4.25%2.05

Frequently Asked Questions about SOLS

What is the current Solstice Advanced Materials Inc. Common Stock (SOLS) stock price?

SOLS is trading at $59.25 at the last market close, down 1.12% on the session. PreMarketPrice tracks SOLS pre-market, intraday and after-hours prices.

Is SOLS stock a buy right now?

PreMarketPrice's quantitative model rates Solstice Advanced Materials Inc. Common Stock's financial health at 42/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is SOLS stock overvalued?

Solstice Advanced Materials Inc. Common Stock trades at a trailing P/E of 44.5 and our valuation score rates it 57/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Solstice Advanced Materials Inc. Common Stock report earnings?

No confirmed earnings date is currently scheduled for SOLS. The Earnings section lists recent reports and updates as dates are announced.

What sector does Solstice Advanced Materials Inc. Common Stock operate in?

Solstice Advanced Materials Inc. Common Stock operates in the Basic Materials sector, within the Chemicals & Allied Products industry. The Related Stocks section lists sector peers for comparison.

What does Solstice Advanced Materials Inc. Common Stock do?

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell.

About Solstice Advanced Materials Inc. Common Stock (SOLS) Stock

Solstice Advanced Materials Inc. Common Stock (SOLS) is a US-listed stock operating in the Basic Materials sector, specifically the Chemicals & Allied Products industry. As of the latest update, Solstice Advanced Materials Inc. Common Stock is trading at $59.25, down 1.12% on the day with a market capitalization of $9.3 billion. The financial health score for SOLS is 42/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for SOLS stock.

SOLS Stock Analysis & Key Metrics

On PreMarketPrice, you can track Solstice Advanced Materials Inc. Common Stock (SOLS) across multiple dimensions:

Is SOLS a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Solstice Advanced Materials Inc. Common Stock (SOLS) as an investment. The financial health score of 42/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Solstice Advanced Materials Inc. Common Stock (SOLS) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Basic Materials
More Chemicals & Allied Products stocks
Cheaper alternatives
Similar fundamentals